These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

156 related articles for article (PubMed ID: 1954167)

  • 41. Melatonin suppresses aromatase expression and activity in breast cancer associated fibroblasts.
    Knower KC; To SQ; Takagi K; Miki Y; Sasano H; Simpson ER; Clyne CD
    Breast Cancer Res Treat; 2012 Apr; 132(2):765-71. PubMed ID: 22237979
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Oestrogen formation in breast: clinical and biological importance.
    Dowsett M; Detre S; Rowlands M; Grimshaw R
    J Endocrinol; 1996 Sep; 150 Suppl():S59-63. PubMed ID: 8943788
    [TBL] [Abstract][Full Text] [Related]  

  • 43. [Aromatase and breast cancer].
    Miller WR; Howie F; Mason I
    Vopr Onkol; 2001; 47(2):182-6. PubMed ID: 11383454
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Aromatase inhibitors for treatment of advanced breast cancer in postmenopausal women.
    Gibson LJ; Dawson C; Lawrence DH; Bliss JM
    Cochrane Database Syst Rev; 2007 Jan; (1):CD003370. PubMed ID: 17253488
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Focus on anastrozole and breast cancer.
    Mokbel K
    Curr Med Res Opin; 2003; 19(8):683-8. PubMed ID: 14687437
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Aromatase expression increases the survival and malignancy of estrogen receptor positive breast cancer cells.
    Mukhopadhyay KD; Liu Z; Bandyopadhyay A; Kirma NB; Tekmal RR; Wang S; Sun LZ
    PLoS One; 2015; 10(4):e0121136. PubMed ID: 25837259
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Correlation of aromatase activity with histological differentiation of breast cancer--a morphometric analysis.
    Lipton A; Santen RJ; Santner SJ; Harvey HA; White-Hershey D; Bartholomew MJ; Sharkey FE
    Breast Cancer Res Treat; 1988 Sep; 12(1):31-5. PubMed ID: 3196885
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Aromatase activity and CYP19 gene expression in breast cancers.
    Sourdaine P; Mullen P; White R; Telford J; Parker MG; Miller WR
    J Steroid Biochem Mol Biol; 1996 Oct; 59(2):191-8. PubMed ID: 9010334
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Adjuvant anastrozole versus exemestane versus letrozole, upfront or after 2 years of tamoxifen, in endocrine-sensitive breast cancer (FATA-GIM3): a randomised, phase 3 trial.
    De Placido S; Gallo C; De Laurentiis M; Bisagni G; Arpino G; Sarobba MG; Riccardi F; Russo A; Del Mastro L; Cogoni AA; Cognetti F; Gori S; Foglietta J; Frassoldati A; Amoroso D; Laudadio L; Moscetti L; Montemurro F; Verusio C; Bernardo A; Lorusso V; Gravina A; Moretti G; Lauria R; Lai A; Mocerino C; Rizzo S; Nuzzo F; Carlini P; Perrone F;
    Lancet Oncol; 2018 Apr; 19(4):474-485. PubMed ID: 29482983
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Oestrogen producing enzymes and mammary carcinogenesis: a review.
    Subramanian A; Salhab M; Mokbel K
    Breast Cancer Res Treat; 2008 Sep; 111(2):191-202. PubMed ID: 17934808
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Aromatisation of androstenedione by human breast cancer tissue: correlation with hormone receptor activity and possible biologic significance.
    Bezwoda WR; Mansoor N; Dansey R; Esser JD
    Oncology; 1987; 44(1):30-3. PubMed ID: 3561925
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Inhibition of aromatase as treatment of breast carcinoma in postmenopausal women.
    Santen RJ; Boucher AE; Santner SJ; Henderson IC; Harvey H; Lipton A
    J Lab Clin Med; 1987 Mar; 109(3):278-89. PubMed ID: 3546561
    [TBL] [Abstract][Full Text] [Related]  

  • 53. [Clinicopathological significance of aromatase expression in breast cancers].
    Lu JS; Li HC; Cao DC; Di GH; Wu J; Shen KW; Shen ZZ; Shao ZM
    Zhonghua Wai Ke Za Zhi; 2006 Oct; 44(19):1318-21. PubMed ID: 17217816
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Transcriptional control of local estrogen formation by aromatase in the breast.
    To SQ; Knower KC; Cheung V; Simpson ER; Clyne CD
    J Steroid Biochem Mol Biol; 2015 Jan; 145():179-86. PubMed ID: 24846828
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Interactions between prostaglandin E(2), liver receptor homologue-1, and aromatase in breast cancer.
    Zhou J; Suzuki T; Kovacic A; Saito R; Miki Y; Ishida T; Moriya T; Simpson ER; Sasano H; Clyne CD
    Cancer Res; 2005 Jan; 65(2):657-63. PubMed ID: 15695411
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Aromatase in human breast carcinoma.
    Perel E; Blackstein ME; Killinger DW
    Cancer Res; 1982 Aug; 42(8 Suppl):3369s-3372s. PubMed ID: 7083202
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Dysregulation of Aromatase in Breast, Endometrial, and Ovarian Cancers: An Overview of Therapeutic Strategies.
    Manna PR; Molehin D; Ahmed AU
    Prog Mol Biol Transl Sci; 2016; 144():487-537. PubMed ID: 27865465
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Efficacy and safety of fulvestrant in postmenopausal patients with hormone receptor-positive advanced breast cancer: a systematic literature review and meta-analysis.
    Wang J; Xu B; Wang W; Zhai X; Chen X
    Breast Cancer Res Treat; 2018 Oct; 171(3):535-544. PubMed ID: 29974356
    [TBL] [Abstract][Full Text] [Related]  

  • 59. The regulation of aromatase activity in breast fibroblasts: the role of interleukin-6 and prostaglandin E2.
    Singh A; Purohit A; Ghilchik MW; Reed MJ
    Endocr Relat Cancer; 1999 Jun; 6(2):139-47. PubMed ID: 10731102
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Immunohistochemical analysis of aromatase in metastatic lymph nodes of breast cancer.
    Shibahara Y; Miki Y; Ishida T; Nakamura Y; Suzuki T; Ohuchi N; Sasano H
    Pathol Int; 2013 Jan; 63(1):20-8. PubMed ID: 23356222
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.